"where's the market?", you say? Um my post showed you exactly where with prevalence rates of DFU's in Indonesia. What a stupid question - seeing as you insist on being brusque.
OK, let me dumb it down for you.
It matters squat how many potential customers you have, if those customers cannot afford to buy your product. Alternatively, it matters squat how many sales you make, if those sales do not provide you with an adequate profit margin. Of the millions of suffers you refer to, most in Indonesia will fall into that demographic.
I hope that clears things up for you and isn't too brusque for your liking.
Incidentally, with regard to your previous great success in some non-defined micro-capped biotech - you may want to bear in mind that 'past performance is not an indicator of future results'. Not financial advice, just a well established investment truism.
- Forums
- ASX - By Stock
- RCE
- Ann: Positive Phase II Data from Clinical Trial of R327 Gel
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-35
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online